Serotonin and GI Disorders: An Update on Clinical and Experimental Studies

Overview

Journal Clin Transl Gastroenterol

Specialty Gastroenterology

Date 2012 Dec 15

PMID 23238212

Citations 76

Authors

Marcus Manocha

Waliul I Khan

Affiliations

Soon will be listed here.

Abstract

The gastrointestinal (GI) tract is the largest producer of serotonin (5-hydroxytryptamine (5-HT)) in the body, and as such it is intimately connected with GI function and physiology. 5-HT produced by enterochromaffin (EC) cells is an important enteric mucosal signaling molecule and has been implicated in a number of GI diseases, including inflammatory bowel disease and functional disorders such as irritable bowel syndrome. This review will focus on what is known of basic 5-HT physiology and also on the emerging evidence for its novel role in activation of immune response and inflammation in the gut. Utilizing pubmed.gov, search terms such as "5-HT," "EC cell," and "colitis," as well as pertinent reviews, were used to develop a brief overview of EC cell biology and the association between 5-HT and various GI disorders. It is the aim of this review to provide the readers with an update on EC cell biology and current understanding on the role of 5-HT in GI disorders specifically in inflammatory conditions.

Citing Articles

Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial.

Safaei F, Shahrokh S, Naderi N, Rastegar R, Shamsi A Front Med (Lausanne). 2024; 11:1468885.

PMID: 39635600 PMC: 11614664. DOI: 10.3389/fmed.2024.1468885.

The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile.

Boustany A, Feuerstadt P, Tillotson G Adv Ther. 2024; 41(11):3982-3995.

PMID: 39276186 PMC: 11480130. DOI: 10.1007/s12325-024-02972-0.

Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?.

Saei Ghare Naz M, Ghasemi V, Amirshekari S, Ramezani Tehrani F Endocrinol Diabetes Metab. 2024; 7(2):e00477.

PMID: 38494583 PMC: 10944984. DOI: 10.1002/edm2.477.

Living, Heat-Killed and Its Cell-Free Supernatant Differentially Regulate Colonic Serotonin Receptors and Immune Response in Experimental Colitis.

Sun Z, Huang S, Yan X, Zhang X, Hao Y, Jiang L Nutrients. 2024; 16(4).

PMID: 38398793 PMC: 10893098. DOI: 10.3390/nu16040468.

Emerging Roles of Gut Serotonin in Regulation of Immune Response, Microbiota Composition and Intestinal Inflammation.

Grondin J, Khan W J Can Assoc Gastroenterol. 2024; 7(1):88-96.

PMID: 38314177 PMC: 10836984. DOI: 10.1093/jcag/gwad020.

References

Rubinstein A . Approaches and opportunities in colon-specific drug delivery. Crit Rev Ther Drug Carrier Syst. 1995; 12(2-3):101-49. DOI: 10.1615/critrevtherdrugcarriersyst.v12.i2-3.10. View

Bearcroft C, Perrett D, Farthing M . 5-hydroxytryptamine release into human jejunum by cholera toxin. Gut. 1996; 39(4):528-31. PMC: 1383264. DOI: 10.1136/gut.39.4.528. View

Kushnir-Sukhov N, Gilfillan A, Coleman J, Brown J, Bruening S, Toth M . 5-hydroxytryptamine induces mast cell adhesion and migration. J Immunol. 2006; 177(9):6422-32. DOI: 10.4049/jimmunol.177.9.6422. View

Talley N, VAN Zanten S, Saez L, Dukes G, Perschy T, Heath M . A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001; 15(4):525-37. DOI: 10.1046/j.1365-2036.2001.00941.x. View

Gershon M . Serotonin: its role and receptors in enteric neurotransmission. Adv Exp Med Biol. 1991; 294:221-30. DOI: 10.1007/978-1-4684-5952-4_20. View

Miwa J, Echizen H, Matsueda K, Umeda N . Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001; 63(3):188-94. DOI: 10.1159/000051888. View

Wade P, Westfall J . Ultrastructure of enterochromaffin cells and associated neural and vascular elements in the mouse duodenum. Cell Tissue Res. 1985; 241(3):557-63. DOI: 10.1007/BF00214576. View

Brown P, Drossman D, Wood A, Cline G, Frazier K, Jackson J . The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology. 2011; 141(2):507-16. PMC: 4905727. DOI: 10.1053/j.gastro.2011.05.005. View

Cremon C, Carini G, Wang B, Vasina V, Cogliandro R, De Giorgio R . Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol. 2011; 106(7):1290-8. DOI: 10.1038/ajg.2011.86. View

10.

Challacombe D, Dawkins P, Baker P . Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease. Gut. 1977; 18(11):882-6. PMC: 1411730. DOI: 10.1136/gut.18.11.882. View

11.

Bjerknes M, Cheng H . Neurogenin 3 and the enteroendocrine cell lineage in the adult mouse small intestinal epithelium. Dev Biol. 2006; 300(2):722-35. DOI: 10.1016/j.ydbio.2006.07.040. View

12.

Li N, Ghia J, Wang H, McClemens J, Cote F, Suehiro Y . Serotonin activates dendritic cell function in the context of gut inflammation. Am J Pathol. 2011; 178(2):662-71. PMC: 3069907. DOI: 10.1016/j.ajpath.2010.10.028. View

13.

Ataee R, Ajdary S, Zarrindast M, Rezayat M, Hayatbakhsh M . Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line. J Cancer Res Clin Oncol. 2010; 136(10):1461-9. DOI: 10.1007/s00432-010-0801-3. View

14.

Kidd M, Gustafsson B, Drozdov I, Modlin I . IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil. 2008; 21(4):439-50. PMC: 4040949. DOI: 10.1111/j.1365-2982.2008.01210.x. View

15.

Costedio M, Coates M, Danielson A, Buttolph 3rd T, Blaszyk H, Mawe G . Serotonin signaling in diverticular disease. J Gastrointest Surg. 2008; 12(8):1439-45. PMC: 2910905. DOI: 10.1007/s11605-008-0536-5. View

16.

Mawe G, Coates M, Moses P . Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther. 2006; 23(8):1067-76. DOI: 10.1111/j.1365-2036.2006.02858.x. View

17.

Crosnier C, Stamataki D, Lewis J . Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet. 2006; 7(5):349-59. DOI: 10.1038/nrg1840. View

18.

Cloez-Tayarani I, Changeux J . Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2006; 81(3):599-606. DOI: 10.1189/jlb.0906544. View

19.

Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G . The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol. 2004; 172(10):6011-9. DOI: 10.4049/jimmunol.172.10.6011. View

20.

Haub S, Ritze Y, Bergheim I, Pabst O, Gershon M, Bischoff S . Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil. 2010; 22(7):826-34, e229. PMC: 3063458. DOI: 10.1111/j.1365-2982.2010.01479.x. View